UCB BioSciences GmbH, based in Monheim, is a legally independent development site of the UCB group. The company performs clinical development, project management and regulatory submission coordination on behalf of the UCB group, with key indication areas being neurology and immunology. In fiscal year 2024 UCB BioSciences generated revenue of €58,187,019.39, which mainly comprised cost reimbursements for research and development services from UCB Biopharma SRL amounting to TEUR 57,488. On average 198 employees were employed, 189 of whom worked in research and development, and the sole shareholder is UCB Pharma GmbH, Monheim.
Forschung und Entwicklung auf dem Gebiet der Human- und Veterinärmedizin einschließlich der Entwicklung von Arzneimitteln, Diagnostika und sonstigen pharmazeutisch-chemischen oder kosmetischen Produkten auch aus dem gentechnologischen und/oder biotechnologischen Bereich
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 46849 (as of 24 September 2026)
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 46849 (as of 24 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Düsseldorf Local Court, HRB 46849 (as of 24 September 2026)
Cellex Cell Professionals GmbH
Köln · Forschung und Entwicklung im Bereich Biotechnologie
Axolabs GmbH
Kulmbach · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Jonas & Redmann Automationstechnik GmbH
Berlin · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Sign in to view detailed salary and cost trends.
